Genetic study suggests ‘causal link’ between vitamin D status and blood pressure
New genetic research provides ‘compelling evidence’ that low levels of vitamin D have a causal role in the development of high blood pressure, say researchers.
New genetic research provides ‘compelling evidence’ that low levels of vitamin D have a causal role in the development of high blood pressure, say researchers.
Dispatches from IFT 2014
Proposals to shift focus to vitamin D, calcium, iron and potassium on the US FDA’s Nutrition Facts Panel make sense, but could remove incentives to fortify with other essential micronutrients, warns DSM.
Sports nutrition firm MusclePharm has concluded a deal with Tiger Woods to feature the comapny’s logo on his golf bag. Woods reportedly will receive an undisclosed annual fee and stock currently worth about $5 million.
The US Food and Drug agency has accepted for review a premarket notification report from 23andMe, seven months after its genetic testing operations were shut down by the FDA.
Dispatches from EFSA plenary, Parma
Energy drink association asks EFSA to aim for precision after an open NDA panel discussion on a draft caffeine safety opinion provides more questions than answers.
Pills or foods? Experts from the world of functional foods will join NutraIngredients-USA for a discussion of the functional foods, from market sizing and key consumer demographics to the regulatory considerations.
The Council for Responsible Nutrition took its ‘tale of two industries’ to Capitol Hill this week for senior level meetings and briefings with key lawmakers, with steroids, weight loss products, and smart prevention featuring on the agenda.
Global food and drink manufacturers should exploit the ‘superfood’ potential of ancient ingredients such as prickly pear cactus and chia seeds, known for their rich nutrient content and health-giving properties, says Mintel global food science analyst,...
Dispatches from EFSA plenary, Parma
Transparency is important, but this may not be compatible with openness of scientific debate, according to the temporary chair of the European Food Safety Authority's (EFSA) Dietetic Products, Nutrition and Allergies (NDA) panel.